Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Apr;37(4):829-37.
doi: 10.1007/s00268-013-1909-9.

Liver resection for Bismuth type I and Type II hilar cholangiocarcinoma

Affiliations
Comparative Study

Liver resection for Bismuth type I and Type II hilar cholangiocarcinoma

Jin Hong Lim et al. World J Surg. 2013 Apr.

Abstract

Background: In patients with Bismuth type I and II hilar cholangiocarcinoma (HCCA), bile duct resection alone has been the conventional approach. However, many authors have reported that concomitant liver resection improved surgical outcomes.

Methods: Between January 2000 and January 2012, 52 patients underwent surgical resection for a Bismuth type I and II HCCA (type I: n = 22; type II: n = 30). Patients were classified into two groups: concomitant liver resection (n = 26) and bile duct resection alone (n = 26).

Results: Bile duct resection alone was performed in 26 patients. Concomitant liver resection was performed in 26 patients (right side hepatectomy [n = 13]; left-side hepatectomy [n = 6]; volume-preserving liver resection [n = 7]). All liver resections included a caudate lobectomy. Patient and tumor characteristics did not differ between the two groups. Although concomitant liver resection required longer operating time (P < 0.001), it had a similar postoperative complication rate (P = 0.764), high curability (P = 0.010), and low local recurrence rate (P = 0.006). Concomitant liver resection showed better overall survival (P = 0.047).

Conclusions: Concomitant liver resection should be considered in patients with Bismuth type I and II HCCA.

PubMed Disclaimer

References

    1. Ann Surg. 1996 Oct;224(4):463-73; discussion 473-5 - PubMed
    1. Hepatogastroenterology. 2012 Mar-Apr;59(114):347-50 - PubMed
    1. Ann Surg. 2003 Feb;237(2):208-17 - PubMed
    1. World J Surg. 2012 May;36(5):1112-21 - PubMed
    1. Am J Transplant. 2012 May;12(5):1229-39 - PubMed

LinkOut - more resources